Lv3
380 积分 2025-09-19 加入
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core
1天前
已完结
Erdafitinib to treat urothelial carcinoma
1个月前
已完结
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
3个月前
已完结
Structure-Based Optimization of the Third Generation Type II Macrocycle TRK Inhibitors with Improved Activity against Solvent-Front, xDFG, and Gatekeeper Mutations
3个月前
已完结
Discovery of Cell-Permeable Macrocyclic Cyclin A/B RxL Inhibitors that Demonstrate Antitumor Activity
3个月前
已完结
具有强效体外和体内抗疟活性的大环模拟肽血浆蛋白酶 X 抑制剂
3个月前
已完结
Discovery of Highly Selective and Potent Macrocyclic JAK2 Inhibitors for the Treatment of MPNs
3个月前
已完结
Secondary Amides of (R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase
9个月前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
9个月前
已完结
皖公网安备34019202002308
